LoginRegister

    Cancer, cardiac among 51 essential drugs under NPPA price cap, check out details

    Written by Ruby Khatun Khatun   |  

    New Delhi: National drug pricing regulator NPPA on Friday said it has capped prices of 51 essential formulations, including those used for the treatment of cancer, pain, heart conditions and skin problems.


    The prices have been slashed in the range of 6 to 53 percent.


    In separate notifications, the drug price regulator said it has notified ceiling prices of 13 formulations while revising the same for 15 formulations.


    Moreover, retail prices of 23 essential formulations have also been notified, National Pharmaceutical Pricing Authority (NPPA) said.


    Drugs whose ceiling prices have been capped includes colon or rectal cancer treatment drug oxaliplatin (injection 100mg), Japanese encephalitis vaccine and measles rubbela vaccine.


    On the other hand, ceiling prices of drugs including anesthetic sevoflurane, Phytomenadione (Vitamin K1) and tuberculosis prevention medicine BCG vaccine have been revised.


    According to highly placed sources in NPPA, the reduction in prices following the latest exercise will range between 6- 53 percent.


    NPPA fixes ceiling price of essential medicines of Schedule I under the Drugs (Prices Control) Order (DPCO) 2013.


    In respect of medicines that are not under price control, manufacturers are allowed to increase the maximum retail price by 10 percent annually.


    The calculation of essential drugs is based on the simple average of all medicines in a particular therapeutic segment with sales of more than 1 percent.


    Set up in 1997, NPPA has been entrusted with the task of fixation/revision of prices of pharma products, enforcement of provisions of DPCO and monitoring of prices of controlled and decontrolled drugs.


    Following are the details






















































































































































































































    Sl. No.Name of the Scheduled
    Formulation    		Dosage form & StrengthUnitCeiling Price

    (Rs.)
    (1)(2)(3)(4)(5)
    1.OxaliplatinInjection 100mg (as licensed)Each Pack4055.10
    2.Acetylsalicylic acidEffervescent/ Dispersible/ Enteric coated Tablet 100 mg1 Tablet0.1625
    3.Japanese Encephalitis Vaccine4mcg to 6mcgEach Pack632.95
    4.Japanese Encephalitis Vaccineup to 3mcgEach Pack482.22
    5.Measles Rubbela VaccineEach Pack
    (0.5ml)    		80.22
    6.SurfactantSuspension for intratracheal instillation (As liensed)Per mg of Phospholipids in the pack60.69
    7.SevofluraneInhalation1 ml24.12
    8.Acetylsalicylic acidTablet 325mg1 Tablet0.50
    9.DesferrioxaminePowder for Injection 500mgEach pack145.91
    10.OxaliplatinInjection 50mg
    (as licensed)    		Each Pack2303.01
    11.Phytomenadione (Vitamin K1)Injection 10mg/ml1 ML43.45
    12.GlutaraldehydeSolution 2%1 ML0.05868
    13.Anti-D immunoglobulinInjection 300mcgEach Pack1936.82
    14.BCG vaccineEach Dose4.32
    15.MorphineSR Tablet 30 mg1 Tablet4.94
    16AlteplasePowder for Injection 20 mgEach Pack17235.00
    17.AlteplasePowder for Injection 50 mgEach Pack35985.00
    18.GadobenateInjection 529 mg/ml1 ML98.90
    19.Haemodialysis fluidAs license1 ML0.03695
    20.FurosemideOral liquid 10 mg/ml1 ML0.29
    21.GlucoseInjection 50%1 ml0.44
    22.Lignocaine (A) + Adrenaline (B)Injection 1% (A) + 1:200000 (5 mcg/ml) (B)1 ML0.41
    23.Calcium gluconateInjection 100 mg/ml1 ML0.50
    24.Dextran-40Injection 10%1 ML0.38
    25.Coagulation factor IXPowder for Injection 600 IUEach Pack11,180.00
    26.DigoxinOral liquid 0.05 mg/ml1 ML0.29
    27.Potassium permanganateCrystals for topical solution1 gm0.40
    28.PilocarpineDrops 4%1 ML10.60























































































































































































    Sl.
    No.    		Name of the
    Scheduled
    Formulation
    / Brand
    Name    		StrengthUnitManufacturer &
    Marketing
    Company    		Retail
    Price (Rs.)
    (1)(2)(3)(4)(5)(6)
    1.Sofosbuvir & VelpatasvirEach film coated tablet contains: Sofosbuvir 400mg, Velpatasvir 100mg28 TabletsM/s Hetero Labs Ltd. / M/s Abbott India Ltd.15625.00
    2.Sofosbuvir & VelpatasvirEach film coated tablet contains: Sofosbuvir 400mg, Velpatasvir 100mg28 TabletsM/s Hetero Labs Ltd. / M/s Cadila Healthcare Ltd.15625.00
    3.Sofosbuvir & VelpatasvirEach film coated tablet contains: Sofosbuvir 400mg, Velpatasvir 100mg28 TabletsM/s Natco Pharma Ltd. /M/s Sun Pharmaceuticals Industries Ltd.15625.00
    4.Sofosbuvir & VelpatasvirEach film coated tablet contains: Sofosbuvir 400mg,
    Velpatasvir 100mg    		28 TabletsM/s Natco Pharma Ltd. / M/s Cipla Ltd.15625.00
    5.Sofosbuvir & VelpatasvirEach film coated tablet contains: Sofosbuvir 400mg,
    Velpatasvir 100mg    		28 TabletsM/s Natco Pharma Ltd.15625.00
    6.Sofosbuvir & VelpatasvirEach film coated tablet contains: Sofosbuvir 400mg, Velpatasvir 100mg28 TabletsM/s Natco Pharma Ltd. / M/s Mylan Pharmaceuticals Pvt. Ltd15625.00
    7.Sofosbuvir & VelpatasvirEach tablet contains: Sofosbuvir 400mg, Velpatasvir 100mg28 TabletsM/s Dr. Reddy's Limited15,625.00
    8Sofosbuvir & VelpatasvirEach tablet contains: Sofosbuvir 400mg, Velpatasvir 100mg28 TabletsM/s Hetro Labs Ltd.15,625.00
    9.Voglibose + MetforminEach tablet contains: Voglibose 0.2mg, Metformin 500mg1 TabletM/s Lupin Ltd.4.84
    10.Voglibose + MetforminEach tablet contains: Voglibose 0.3mg, Metformin 500mg1 TabletM/s Lupin Ltd.5.76
    11.Voglibose + Metformin + GlimepiridEach tablet contains: Voglibose 0.2mg, Metformin 500mg, Glimepirid 1mg1 TabletM/s Lupin Ltd.7.14
    12.Voglibose + Metformin + GlimepiridEach tablet contains: Voglibose 0.2mg, Metformin 500mg, Glimepirid 1mg1 TabletM/s Sanofi India Ltd.7.14
    13.Voglibose + Metformin + GlimepiridEach tablet contains: Voglibose 0.2mg, Metformin 500mg, Glimepirid 1mg1 TabletM/s Biocon Ltd.7.14
    14.Voglibose + Metformin + GlimepiridEach tablet contains: Voglibose 0.2mg, Metformin 500mg, Glimepirid 2mg1 TabletM/s Lupin Ltd.9.05
    15.Voglibose + Metformin + GlimepiridEach tablet contains: Voglibose 0.2mg, Metformin 500mg, Glimepirid 2mg1 TabletM/s Sanofi India Ltd.9.05
    16.Voglibose + Metformin + GlimepiridEach tablet contains: Voglibose 0.2mg Metformin 500mg Glimepirid 2mg1 TabletM/s Biocon Ltd.9.05
    17.Voglibose + Metformin + GlimepiridEach tablet contains: Voglibose 0.3mg, Metformin 500mg, Glimepirid 1mg1 TabletM/s Lupin Ltd.8.52
    18.Voglibose + Metformin + GlimepiridEach tablet contains: Voglibose 0.3mg, Metformin 500mg, Glimepirid 1mg1 TabletM/s Alembic Ltd.8.52
    19.Voglibose + Metformin + GlimepiridEach tablet contains: Voglibose 0.3mg, Metformin 500mg, Glimepirid 2mg1 TabletM/s Lupin Ltd.10.46
    20.Diclofenac + TramadolEach tablet contains: Diclofenac 75mg, Tramadol 50mg1 TabletM/s Alembic Ltd.9.73





































    Sl.
    No
    .    		Name of the Scheduled

    Formulation    		Dosage form & StrengthUnitCeili ng Price (Rs.)Review Order
    number and
    date    		Existing SO number and
    date    		Manufacturer &
    Marketing Company
    respectively
    (1)(2)(3)(4)(5)(6)(7)(8)
    1.Trypsin, Bromelain, Rutoside Trihydrate, & Diclofenac Sodium (Volitra Enzo) tabletEach enteric coated tablet contains: Trypsin 48mg, Bromelain 90mg, Rutoside Trihydrate 100mg, Diclofenac Sodium 50mg1 Tablet13.9131015/09/2017 -Pricing dated 27.08.20174131(E) dated 22.12.2016(at Sl. No. 5)M/s Akums Drugs & Pharmaceuticals Ltd./ M/s Sun Pharmaceuticals Ind. Ltd.











































    Sl.
    No.    		Name of the Scheduled FormulationDosage form &
    Strength    		UnitCeilin
    g
    Price
    (Rs.)    		Review Order
    number and
    date    		Existing SO number
    and date
    (1)(2)(3)(4)(5)(6)(7)
    1.CeftriaxonePowder for Injection 1gmEach
    Pack    		48.9231015/59/2017-Pricing dated 10.10.20172058(E) dated 30.6.2017 (at Sl. No. 120)
    2.ChloroquineTablet 150mg1 Tablet0.7231015/32/2017- Pricing dated 24.8.20172059(E) dated 30.6.2017 (at Sl. No. 23)


    Medical Dialogues had earlier reported that NPPA had fixed the ceiling price for 39 more drug formulations, including those used for the treatment of cancer, tuberculosis, malaria and hepatitis B among others.


    Read also: NPPA slashes price of 39 drugs: check out details
    51 essential drugsAnestheticcancercardiacceiling pricesDPCODrugs Prices Control Orderessential drugsessential formulationsheart conditionsNational Pharmaceutical Pricing AuthorityNPPAoxaliplatinPhytomenadioneprice caprectal cancerrubbela vaccinesevofluraneskin problems
    Source : With Agency Inputs

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Ruby Khatun Khatun
    Ruby Khatun Khatun
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X